Advertisement
UK markets closed

  • FTSE 100

    8,213.49
    +41.34 (+0.51%)
     

  • FTSE 250

    20,164.54
    +112.24 (+0.56%)
     

  • AIM

    771.53
    +3.42 (+0.45%)
     

  • GBP/EUR

    1.1660
    +0.0008 (+0.07%)
     

  • GBP/USD

    1.2563
    +0.0017 (+0.14%)
     

  • Bitcoin GBP

    50,584.95
    -244.57 (-0.48%)
     

  • CMC Crypto 200

    1,364.74
    +52.11 (+3.97%)
     

  • S&P 500

    5,180.74
    +52.95 (+1.03%)
     

  • DOW

    38,852.27
    +176.59 (+0.46%)
     

  • CRUDE OIL

    78.69
    +0.21 (+0.27%)
     

  • GOLD FUTURES

    2,332.90
    +24.30 (+1.05%)
     

  • NIKKEI 225

    38,236.07
    -38.03 (-0.10%)
     

  • HANG SENG

    18,578.30
    +102.38 (+0.55%)
     

  • DAX

    18,175.21
    +173.61 (+0.96%)
     

  • CAC 40

    7,996.64
    +39.07 (+0.49%)
     

Hikma says to buy Egyptian pharma firm EIMC United

Reuters - UK Focus

Sept 8 (Reuters) - Hikma Pharmaceutical Plc said it would buy nearly the entire share capital of EIMC United Pharmaceuticals, a drugmaker specialising in oncology products, from a consortium of shareholders to strengthen its position in the Egyptian market.

Hikma, which makes and markets branded and non-branded generic and injectable drugs, did not disclose the value of the deal. Hikma's Egyptian unit has presently a 2 percent market share in that country. (Reporting by Esha Vaish in Bengaluru; Editing by Gopakumar Warrier)